Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-07-01 Hale David Robert Director Shares withheld for taxes −34 $23.78 $809 17,840
2016-06-30 INGRAM ROBERT ALEXANDER Director Grant or award +1,080 $20.14 $22K 87,598
2016-06-30 ROBERTSON RUSSEL C Director Grant or award +312 $20.14 $6K 17,038
2016-06-30 WECHSLER AMY B Director Grant or award +225 $20.14 $5K 16,951
2016-06-17 KARABELAS ARGERIS N Director Grant or award +16,726 16,726
2016-06-17 ROBERTSON RUSSEL C Director Grant or award +16,726 16,726
2016-06-17 POWER ROBERT N Director Grant or award +16,726 32,822
2016-06-17 INGRAM ROBERT ALEXANDER Director Grant or award +16,726 86,518
2016-06-17 WECHSLER AMY B Director Grant or award +16,726 16,726
2016-06-17 ESHELMAN FREDRIC N Director Grant or award +16,726 17,822
2016-06-17 Ross Thomas W. Sr. Director Grant or award +16,726 17,822
2016-06-17 Hale David Robert Director Grant or award +16,726 17,874
2016-06-13 Ross Thomas W. Sr. Director Purchase +4,000 $24.40 $98K 21,882
2016-06-10 PAPA JOSEPH C CHAIRMAN & CEO Purchase +202,000 $24.48 $4.9M 2,442,199
2016-06-09 PAPA JOSEPH C CHAIRMAN & CEO Grant or award · Non-Qualified Stock Options (right to purchase) +682,652 682,652
2016-06-09 Pershing Square Capital Management, L.P. Director Purchase · Put Option (call equivalent position) −9,120,000 $35.80 $326.5M 0
2016-06-09 Pershing Square Capital Management, L.P. Director Sale · Call Option (call equivalent position) −9,120,000 $0.03 $274K 0
2016-06-09 Pershing Square Capital Management, L.P. Director Purchase · Call Option (call equivalent position) +91,200 $4.00 $365K 91,200
2016-06-09 Pershing Square Capital Management, L.P. Director Sale · Put Option (call equivalent position) +9,120,000 $37.09 $338.3M 9,120,000
2016-05-12 Whitaker Anne Clem EVP, Company Group Chairman Grant or award +37,935 165,390

Page 42 of 43 · 851 trades